Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com 0 Related Posts SAGA Metals Announces Closing of $700,000 Private Placement and Receives Drill Permits for Double Mer Uranium and Radar Titanium-Vanadium Maiden Drill Programs December 24, 2024 Lode Gold Announces $350,000 Non-Brokered Financing December 24, 2024 Cannabis Market 2024 Year-End Review December 24, 2024
SAGA Metals Announces Closing of $700,000 Private Placement and Receives Drill Permits for Double Mer Uranium and Radar Titanium-Vanadium Maiden Drill Programs December 24, 2024